Every 10-Q that Cadre Holdings, Inc. (CDRE) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow CDRE and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full CDRE filings page.
Cadre Holdings, Inc. reported strong top-line growth for the three and six months ended June 30, 2026. Net sales rose to $207.1 million for the quarter, up 31.8% from $157.1 million, and to $362.6 million year-to-date, up 26.2%. Gross profit reached $87.1 million for the quarter. Operating income increased to $22.5 million, while quarterly net income edged down to $11.4 million from $12.2 million as higher contingent consideration, compensation, interest expense and adverse foreign currency effects offset margin gains. Adjusted EBITDA grew to $42.0 million in the quarter and $63.1 million year-to-date.
The company accelerated its acquisition strategy, closing the $185.2 million TYR Tactical deal and the $10.3 million Alien Gear holsters acquisition, expanding the Product segment and increasing goodwill and intangibles to $408.1 million. Total assets rose to $917.3 million, funded partly by higher term debt of $375.9 million, while cash, cash equivalents and restricted cash declined to $57.7 million. Orders backlog nearly doubled to $367.7 million, supported by large orders for blast attenuation seats, sensors, remotely operated vehicles, nuclear safety products and duty gear holsters, providing visibility into future revenue.
Cadre Holdings reported higher sales but sharply lower profit for the quarter ended March 31, 2026. Net sales rose to $155.4 million from $130.1 million, driven mainly by recent acquisitions, including TYR Tactical, which added new product lines and customers.
Despite this 19.5% sales increase, net income fell to $2.0 million from $9.2 million. Profit was pressured by higher manufacturing costs, inventory step-up amortization, increased compensation, transaction and related party expenses tied to acquisitions, and higher interest expense from additional debt. Adjusted EBITDA was relatively stable at $21.1 million versus $20.5 million.
Cadre used significant cash for acquisitions, reducing cash and cash equivalents to $41.3 million, while total debt rose to $365.8 million (gross). Orders backlog increased to $355.4 million, reflecting strong demand in explosive ordnance disposal, TYR products, nuclear safety solutions and duty gear.
Cadre Holdings (CDRE) reported strong Q3 2025 growth. Net sales rose to $155.9 million from $109.4 million a year ago, lifting gross profit to $66.6 million from $40.0 million. Operating income increased to $18.7 million from $5.4 million, and net income improved to $10.9 million from $3.7 million, equal to diluted EPS of $0.27 versus $0.09. For the nine months, net sales reached $443.1 million (from $391.6 million) and diluted EPS was $0.79 (from $0.58).
The balance sheet expanded following M&A and credit facility draws. Total assets were $792.1 million (from $652.7 million) with cash and cash equivalents of $150.9 million. Long-term debt, net, was $295.0 million (from $211.8 million), reflecting the April draw of $97.5 million under the delayed draw term loan A‑1 to fund the Zircaloy acquisition, which had total consideration, net, of $89.6 million. Operating cash flow was $42.5 million (versus $8.1 million) year-to-date. The company declared quarterly dividends of $0.095 per share in each quarter of 2025 to date. Remaining performance obligations were $69.9 million as of September 30, 2025, with approximately 51% expected over the next twelve months.